PD-1/PD-L1 signaling in neurological and psychiatric disorders: neuroimmune mechanisms and therapeutic potential.

Xiangning Chen; Xingjun Wang; Chengwei Li; Kaiyue Shan; Lezhen Wang; Kenji Hashimoto; Kai Shao; Penghui Wei; Jian-Jun Yang

doi:10.1016/j.bbi.2026.106965

SCHEDA SCIENTIFICA2026Altra ricerca

PD-1/PD-L1 signaling in neurological and psychiatric disorders: neuroimmune mechanisms and therapeutic potential.

Xiangning Chen, Xingjun Wang, Chengwei Li, Kaiyue Shan, Lezhen Wang, Kenji Hashimoto, Kai Shao, Penghui Wei, Jian-Jun Yang

Brain, behavior, and immunity · 2026

Psicoterapia Neuroscienze

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansMental DisordersProgrammed Cell Death 1 ReceptorSignal TransductionAnimalsB7-H1 AntigenNervous System DiseasesNeuroimmunomodulationNeuroinflammatory DiseasesBrainImmune checkpointMicrogliaNeuroinflammationNeurologicaland psychiatric disordersPD-1/PD-L1T cells

Come citare questo studio

Xiangning Chen, Xingjun Wang, Chengwei Li, Kaiyue Shan, Lezhen Wang, Kenji Hashimoto, Kai Shao, Penghui Wei, Jian-Jun Yang. (2026). PD-1/PD-L1 signaling in neurological and psychiatric disorders: neuroimmune mechanisms and therapeutic potential.. Brain, behavior, and immunity. DOI: 10.1016/j.bbi.2026.106965

Consulta la pubblicazione originale ↗